Pierre Tiberghien

15.2k total citations · 2 hit papers
296 papers, 8.6k citations indexed

About

Pierre Tiberghien is a scholar working on Immunology, Hematology and Epidemiology. According to data from OpenAlex, Pierre Tiberghien has authored 296 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Immunology, 90 papers in Hematology and 54 papers in Epidemiology. Recurrent topics in Pierre Tiberghien's work include Hematopoietic Stem Cell Transplantation (68 papers), Immune Cell Function and Interaction (62 papers) and T-cell and B-cell Immunology (49 papers). Pierre Tiberghien is often cited by papers focused on Hematopoietic Stem Cell Transplantation (68 papers), Immune Cell Function and Interaction (62 papers) and T-cell and B-cell Immunology (49 papers). Pierre Tiberghien collaborates with scholars based in France, United States and Netherlands. Pierre Tiberghien's co-authors include Philippe Saas, Christophe Ferrand, Frédéric Deschaseaux, Émilie Gaiffe, Zohair Selmani, Laurent Obert, Nathalie Rouas‐Freiss, Abderrahim Naji, Edgardo D. Carosella and Christophe Borg and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Pierre Tiberghien

284 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells

2007 845 citations Philippe Saas, Pierre Tiberghien et al. profile →
Age of Transfused Blood in Critically Ill Adults

2015 371 citations Pierre Tiberghien et al. profile →

Peers

Countries citing papers authored by Pierre Tiberghien

Since Specialization

Citations

This map shows the geographic impact of Pierre Tiberghien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Tiberghien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Tiberghien more than expected).

Fields of papers citing papers by Pierre Tiberghien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Tiberghien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Tiberghien. The network helps show where Pierre Tiberghien may publish in the future.

Co-authorship network of co-authors of Pierre Tiberghien

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Tiberghien. A scholar is included among the top collaborators of Pierre Tiberghien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Tiberghien. Pierre Tiberghien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Balancing Donor Health and Plasma Collection: A Systematic Review of the Impact of Plasmapheresis Frequency 2024 ·Transfusion Medicine Reviews ·(unknown), Katja van den Hurk, (unknown), Susan Mikkelsen, (unknown), Emmy De Buck, Peter O’Leary, Pierre Tiberghien, Veerle Compernolle, Christian Erikstrup, Hans Van Remoortel	1
2	End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral 2024 ·Vox Sanguinis ·Antoine Lewin, Mindy Goldman, Michael P. Busch, Katy Davison, Thijs van de Laar, Pierre Tiberghien, Eilat Shinar, Sheila F. O’Brien, Gilles Lambert, Stephen K. Field, Tor Hervig, Darrell H. S. Tan, Brian Custer, Steven J. Drews, Marion C. Lanteri, (unknown), Eleonora Widmer, (unknown), Christian Renaud, Marc Germain	7
3	Frequencies and causes of ABO‐incompatible red cell transfusions in France, Germany and the United Kingdom 2024 ·British Journal of Haematology ·(unknown), (unknown), (unknown), Susanne Müller, (unknown), Lucile Malard, Michael Murphy, Pascale Richard, (unknown), Megan Rowley, (unknown), (unknown), Markus B. Funk, (unknown), Pierre Tiberghien, Richard Schäfer	2
4	Very‐high frequency plasmapheresis and donor health–absence of evidence is not equal to evidence of absence 2023 ·Transfusion ·Hans Van Remoortel, Katja van den Hurk, Veerle Compernolle, Peter O’Leary, Pierre Tiberghien, Christian Erikstrup	3
5	Early and out‐of‐hospital use of COVID‐19 convalescent plasma: An international assessment of utilization and feasibility 2022 ·Vox Sanguinis ·Arwa Z. Al‐Riyami, Lise J Estcourt, Naomi Rahimi‐Levene, Evan M. Bloch, Ruchika Goel, Pierre Tiberghien, (unknown), Mie Topholm Bruun, Dana V. Devine, Richard R. Gammon, Silvano Wendel, (unknown), (unknown), (unknown), Íñigo Romón, Karin van den Berg, Junichi Kitazawa, Gopal Kumar Patidar, Cynthia So‐Osman, Erica M. Wood, (unknown)	4
6	The transfusion of non‐prophylactically RH‐KEL1 antigen‐matched red blood cells is feasible in selected myelodysplastic syndrome and acute myeloid leukaemia patients 2022 ·Vox Sanguinis ·Aliénor Xhaard, Elsa Miekoutima, France Pirenne, Anne Isabelle François, Pierre Tiberghien, Marie Sébert, Lionel Adès, Pierre Fenaux, (unknown)	2
7	The evolving blood donor deferral policy for men who have sex with men: impact on the risk of HIV transmission by transfusion in France 2020 ·Transfusion ·Josiane Pillonel, Camille Pelat, Pierre Tiberghien, Claire Sauvage, Bruno Danic, Christophe Martinaud, Françis Barin, (unknown), B. Coignard, Sylvie Gross, Syria Laperche, Florence Lot	24
8	Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells 2011 ·Cancer Research ·Romain Bedel, Antoine Thiery-Vuillemin, Camille Grandclément, Jérémy Balland, Jean-Paul Rémy-Martin, B Kantelip, Jean‐René Pallandre, Xavier Pivot, Christophe Ferrand, Pierre Tiberghien, Christophe Borg	94
9	A Single Intravenous Infusion of Apoptotic Cells, An Alternative Cell-Based Therapy Approach Facilitating Hematopoietic Cell Engraftment, Did Not Induce Autoimmunity 2003 ·Journal of Hematotherapy & Stem Cell Research ·Sylvain Perruche, (unknown), R Angonin, Jean‐Yves Cahn, Éric Deconinck, Luc Reininger, José Boucraut, Pierre Tiberghien, Philippe Saas	11
10	La réactivité allogénique dirigée contre le receveur lors d‘une greffe hématopoïétique 2003 ·Bulletin du Cancer ·Pierre Tiberghien, (unknown), Christophe Ferrand, Philippe Saas, Patrick Hervé	1
11	Influence of Ex Vivo Expansion and Retrovirus-Mediated Gene Transfer on Primary T Lymphocyte Phenotype and Functions 2002 ·Journal of Hematotherapy & Stem Cell Research ·Delphine Sauce, (unknown), Anne Duperrier, (unknown), Manoel de Carvalho, (unknown), Philippe Saas, Christophe Ferrand, Patrick Hervé, Pierre Tiberghien, Éric Robinet	26
12	[Challenges of transfusion medicine]. 2001 ·PubMed ·Patrick Hervé, Pierre Tiberghien	1
13	Development of a Competitive PCR Method for In Vitro and In Vivo Quantification of Herpes Simplex Virus Thymidine Kinase and Neomycin Resistance-Expressing Cells Used in a Clinical Trial 2000 ·Journal of Hematotherapy & Stem Cell Research ·Stéphane Maddens, Pierre Tiberghien, Emmanuel Contassot, (unknown), David Chalmers, E Otto, Patrick Hervé, Christophe Ferrand	13
14	La réaction du greffon contre l’hôte : un modèle de dysrégulation cytokinique ? 2000 ·Hématologie ·Éric Robinet, Pierre Tiberghien	3
15	The graft-versus-host disease : a cytokine dysregulation model ? 2000 ·Hématologie ·Éric Robinet, Pierre Tiberghien	1
16	Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. 2000 ·Blood ·A. John Barrett, Olle Ringdén, Mei‐Jie Zhang, Asad Bashey, Jean‐Yves Cahn, Mitchell S. Cairo, Robert Peter Gale, Aloïs Gratwohl, Franco Locatelli, Rodrigo Martino, Kirk R. Schultz, Pierre Tiberghien	66
17	Quelles sont aujourd'hui les nouvelles stratégies susceptibles de faire progresser la sécurité transfusionnelle en France? 1999 ·(unknown), (unknown), Patrice Morel, Pierre Tiberghien	2
18	[What present strategies are helpful in improving transfusion safety in France?]. 1999 ·PubMed ·P Hervé, V. Lapierre, Pascal Morel, Pierre Tiberghien	2
19	A Closed Culture System for the Ex Vivo Transduction and Expansion of Human T Lymphocytes 1998 ·Journal of Hematotherapy ·Éric Robinet, (unknown), Christophe Ferrand, Phillip B. Maples, (unknown), Jean‐Yves Cahn, Craig W. Reynolds, (unknown), Patrick Hervé, Pierre Tiberghien	30
20	Retroviral-Mediated Marker Gene Transfer in Hematopoiesis-Supportive Marrow Stromal Cells 1998 ·Journal of Hematotherapy ·Claude‐Eric Bulabois, (unknown), (unknown), P. Fixe, (unknown), Patrick Hervé, Pierre Tiberghien, Pierre Charbord	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact